Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic myelomonocytic leukemia.

John M Bennett1

  • 1University of Rochester Medical Center, James P. Wilmot Cancer Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA. john_bennett@urmc.rochester.edu

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary

Chronic myelomonocytic leukemia (CMML) is a challenging blood cancer. Treatment options like hydroxyurea or stem cell transplants offer hope, but clinical trials are crucial for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

HemaSphere·2026
Same author

Unique structural and ligand-binding properties of the <i>Staphylococcus aureus</i> serine hydrolase FphE.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Unique structural and ligand binding properties of the <i>Staphylococcus aureus</i> serine hydrolase FphE.

bioRxiv : the preprint server for biology·2025
Same author

The evolving nosology of myeloid neoplasms: the semi-centennial of the 1976 French-American-British classification.

Leukemia·2025
Same author

Chemoenzymatic Skeletal Editing of Natural Product Scaffolds via P450-Controlled Site-Selective Ring Expansion at Aliphatic C─H Sites.

Angewandte Chemie (International ed. in English)·2025
Same author

Identification of covalent inhibitors of Staphylococcus aureus serine hydrolases important for virulence and biofilm formation.

Nature communications·2025

Area of Science:

  • Hematology
  • Oncology

Background:

  • Chronic myelomonocytic leukemia (CMML) presents with both myelodysplastic and proliferative characteristics.
  • The median age for CMML diagnosis is 70 years, with a median survival of approximately 2 years.

Purpose of the Study:

  • To review current treatment strategies for Chronic myelomonocytic leukemia (CMML).
  • To highlight the limited success of existing therapies and the need for improved interventions.

Main Methods:

  • Review of established and emerging treatment modalities for CMML.
  • Discussion of therapeutic options based on disease phase and patient-specific factors.

Main Results:

  • Chemotherapy regimens have yielded only modest success in treating CMML.
  • Hydroxyurea is the preferred treatment when the proliferative phase is dominant.
  • Allogeneic bone marrow transplantation is recommended for younger, high-risk CMML patients.

Conclusions:

  • For CMML patients lacking a suitable donor, combination acute myeloid leukemia-type therapy followed by autologous stem cell transplant is an alternative.
  • Participation in clinical trials is strongly encouraged due to suboptimal therapeutic outcomes.

Related Experiment Videos